Alpha Cancer: Project Description

Alpha Cancer Technologies (ACT) is a clinical-stage biotechnology company developing therapies in immuno-oncology, radiopharmaceuticals, and immunomodulation using its proprietary recombinant human alpha fetoprotein (AFP) platform.

I stepped into their existing infrastructure and built a modern, polished landing page aimed at clients and investors. The goal was to bring clarity, updated UI, and streamlined messaging to a high-stakes audience — while fitting into their broader biotech digital ecosystem.